Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the Treating to New Targets [TNT] study). Am J Cardiol. 2007;100: 747 752. 43. Hayward RA, Krumholz HM, Zulman DM, Timbie JW, Vijan S. Opti- mizing statin treatment for primary prevention of coronary artery disease [published correction appears in Ann Intern Med. 2011;154:848]. Ann Intern Med. 2010;152:69 77. 44. Kris-Etherton PM, Harris WS, Appel LJ; for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease [published correction appears in Circulation. 2003;107:512]. Circulation. 2002;106:2747 2757. 45. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112:298 304. 46. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pin a IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the pre- vention of cardiovascular disease in women: 2011 update: a guideline from the American Heart Association [published correction appears in Circulation. 2011;123:e624]. Circulation 2011;123:1243 1262. 47. 